Choisir une catégorie :

- Valbiotis announces the first visit of the first patientin the TOTUM•63 mode of action clinical study conducted by the INAF1, in partnership with Nestlé Health Science

Voir le communiqué de presse

- Signing of a Term Sheet for €100 million in syndicated financing to support the Group’s growth (IN FRENCH).

Voir le communiqué de presse

- How can and should health and climate-conscious agricultural approaches create value in our territories ? (IN FRENCH).

Voir le communiqué de presse

- Valbiotis announces the positive results of its clinical study on the bioavailability and mode of action of TOTUM•070,against hypercholesterolemia.

Voir le communiqué de presse

- Valbiotis is strengthening its commitment to CSR by joining the United Nations Global Compact and applying the ISO 26000 standard

Voir le communiqué de presse